| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of 1Psychology and 2Anatomy and Structural Biology, University of Otago, Dunedin, New Zealand
Submitted 19 December 2003; accepted in final form 30 June 2004
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
-amino-4-carboxy-2-methylbenzeneacetic acid (LY367385) demonstrated that the effect of inhibiting tyrosine phosphatases is not specific to either subtype of mGluR. These results suggest that the depression of the sAHP induced by activation of mGluR1 and -5 is gated by a balance between tyrosine phosphorylation and dephosphorylation. |
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
; Schrader et al. 2002) and hence would be expected to play an important role in learning and memory. Indeed, postlearning changes in cell excitability have been demonstrated (e.g., Coulter et al. 1989). Changes in excitability can be effected by modulation of the spike afterhyperpolarization, in particular the slow afterhyperpolarization (sAHP) that is a principal determinant of firing frequency and spike frequency adaptation in hippocampal pyramidal neurons (Storm 1990). In these cells, activation of a variety of neurotransmitter receptors including metabotropic glutamate receptors (mGluRs) strongly depresses the sAHP (Pedarzani and Storm 1993) and as a result increases cell excitability. In CA1 pyramidal neurons of adult rats, the mGluR-induced depression of the sAHP and accompanying increase in excitability is dependent on both subtypes of Group I mGluR, mGluR1 and -5 (Ireland and Abraham 2002; Mannaioni et al. 1999, 2001). Typically, metabotropic actions of receptors are transduced by intracellular signaling pathways, but previous attempts to elucidate the signaling pathway(s) involved in the mGluR-induced depression of the sAHP in pyramidal neurons of the CA1 region in rat hippocampus have failed to identify the enzymes in question. Nevertheless, these studies have demonstrated that although Group I mGluRs classically couple to phosphoinositide hydrolysis (Abe et al. 1992; Aramori and Nakanishi 1992), none of phospholipase C (PLC), protein kinase C, and inositol 1,4,5-trisphosphate (IP3)-sensitive Ca2+ stores are involved (Ireland and Abraham 2002; Nouranifar et al. 1998). In addition, the depression of the sAHP current is not dependent on protein kinase A or Ca2+/calmodulin-dependent kinase II (Pedarzani and Storm 1996). These findings suggest that Group I mGluRs regulate the sAHP by a nonclassical pathway. In dentate gyrus granule cells, the mGluR-dependent suppression of the current underlying the sAHP has been shown to be dependent on tyrosine kinase activity (Abdul-Ghani et al. 1996), but the role that tyrosine phosphorylation plays in mGluR depression of the sAHP has not been previously examined in CA1 neurons. The present study therefore aimed to determine the role, if any, of tyrosine phosphorylation in the mGluR-mediated depression of the sAHP in CA1. Our results demonstrate that both the mGluR1- and mGluR5-triggered depression of the sAHP in CA1 neurons are promoted by tyrosine dephosphorylation of a regulatory protein. Portions of these data have been reported in preliminary form (Ireland and Abraham 2003). |
METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
Transverse hippocampal slices (400 µm) were prepared from young adult male Sprague-Dawley rats (6–8 wks). All procedures were performed in accordance with New Zealand animal welfare legislation, and the experiments and procedures were approved by the University of Otago Committee on Ethics in the Care and Use of Laboratory Animals. Rats were anesthetized with ketamine (100 mg/kg ip) and decapitated, and the brain was quickly removed and cooled with ice-cold artificial cerebrospinal fluid (ACSF). The hippocampi were dissected free, and area CA3 was removed with a manual knife-cut to reduce potential hyperexcitability and/or slow-onset potentiation (Bortolotto and Collingridge 1993). Slices were transferred to a humidified recording chamber and superfused (2 ml/min) with ACSF of the following composition (in mM): 124 NaCl, 3.2 KCl, 1.25 NaH2PO4, 26 NaHCO3, 2.5 CaCl2, 1.3 MgCl2, and 10 glucose (equilibrated with 95% O2-5% CO2). Before recording, slices were allowed to equilibrate for 2 h while the temperature was increased slowly to 32.5°C.
Intracellular recording
Intracellular recording microelectrodes were pulled from borosilicate glass and filled with 2 M potassium acetate (resistances: 70–130 M
). Current-clamp recordings were made from CA1 pyramidal neurons using an Axoclamp 2A amplifier (Axon instruments) and pCLAMP 8.0 software (Axon instruments), and data were stored on a computer for off-line analysis using pCLAMP 8.0 software. The membrane potential of the impaled neuron was held constant throughout the experiment at –65 mV by manually adjusting the holding current. The sAHP was induced once every 2 min by a train of four action potentials, each elicited by a separate depolarizing current pulse (2 ms, 3 nA, 5-ms interpulse interval). sAHP amplitude was measured at peak amplitude and expressed as a percentage change from baseline values. In some cells, the inhibition of the sAHP revealed a small afterdepolarization, and in these cases, the percentage change in the amplitude of the afterhyperpolarization was capped at –100%. The number of action potentials fired by a depolarizing current pulse (0.5 nA, 250 ms) was recorded once every 2 min as a measure of cell excitability and is expressed as the difference in the number of spikes from baseline values. Only one cell was studied per slice.
Drugs were applied by bath perfusion, and all inhibitors were applied for 
20 min prior to addition of (RS)-3,5-dihydroxyphenylglycine (DHPG), which was applied for 10 min. Doses of drugs were chosen based both on experience in our laboratory and on previous studies in hippocampal slices. The effects of DHPG on the sAHP peak amplitude and excitability were quantified by averaging the last 2 data points (i.e., the last 4 min) of drug application. Statistical significance of drug effects was determined by performing unpaired Student's t-test between drug groups at the P < 0.05 significance level, and data are presented as means ± SE.
Western Blot procedure
PROTEIN EXTRACTS.
Hippocampal slices were incubated in 35-mm tissue culture wells containing 1 ml ASCF in a humidified and oxygenated atmosphere for 2 h while the temperature was slowly raised to 32.5°C. Once this temperature was reached, four slices were exposed to each of the four different conditions (no drug, sodium orthovanadate, lavendustin A, lavendustin A plus orthovanadate). In the lavendustin plus orthovanadate group, lavendustin was added 20 min prior to orthovanadate. Two of the slices in each condition were removed and immediately frozen, while the remaining two slices in each condition were rinsed in ACSF and the incubation continued for 1 h. Subsequently, protein cellular extracts were prepared from the frozen slices by sonication in the following buffer (in mM): 20 Tris.Cl (pH 7.6), 1 EDTA, 2 dithiothreitol (DTT), 0.1 phenyl methanesulfonyl fluoride (PMSF), 25 NaF, 10 sodium pyrophosphate (NaPPi), 10 Complete protease inhibitor (Roche), 10 3-[(3-cholamidopropyl) dimethylammonio]-1-propane sulfonate (CHAPS), 0.5% SDS, and 1 orthovanadate and 10 µM lavendustin A according to Williams et al. (1998). Protein concentration was estimated using bicinchoninic acid (BCA) assay (Smith et al. 1985) with BSA protein standards.
QUANTITATIVE WESTERN BLOT ANALYSIS. Equal amounts of protein extracts (25 µg) were separated by SDS-PAGE (9%) and transferred to nitrocellulose membrane (Schleicher and Schuell). Membranes were probed with PY99 monoclonal antibody (Santa Cruz Biotechnology) to detect tyrosine phosphorylated residues. Antibody binding was detected using HRP-conjugated secondary antibodies (DAKO) and enhanced chemiluminescence (Amersham). Autoradiographs were scanned using a BioRad imaging densitometer and quantified using Molecular Analyst software. To ensure that the densitometric analysis was carried out within the linear range of the film, standard curves were established and multiple exposures taken. Only the most prominent band (180 kDa) was quantitated as it was representative of the other visible bands. Results are expressed as the ratio of tyrosine phosphorylation in each drug-treated group to tyrosine phosphorylation in the no-drug control group. Statistical significance was determined by performing paired Student's t-test at the P < 0.05 significance level.
Drugs and chemicals
All salts were obtained from BDH Chemicals (Poole, UK); (RS)-DHPG, lavendustin A, genistein, LY367385, MPEP, and PP2 from Tocris Cookson (Bristol, UK); sodium orthovanadate from Sigma. Drugs were dissolved in H2O (RS-DHPG, MPEP, orthovanadate), 100 mM NaOH (LY367385), or dimethyl sulfoxide (lavendustin A, genistein, PP2) and diluted 1000-fold to their final concentration in ACSF.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
In the first experiment, we replicated our previous report (Ireland and Abraham 2002) that the Group I-specific mGluR agonist DHPG produces a rapid-onset and persistent depression of the sAHP in CA1 neurons and a corresponding increase in excitability. Application of DHPG (20 µM) for 10 min acutely reduced the peak amplitude of the sAHP by –91 ± 3% of baseline (n = 14) followed by a long-lasting depression (Fig. 1, A and C). When measured 40 min after washout of agonist, the sAHP had recovered to –56 ± 4% of baseline (n = 10). DHPG also produced an acute increase in excitability of 7.6 ± 0.6 spikes/pulse above baseline (n = 14) that had recovered to 1.7 ± 0.6 spikes/pulse above baseline (n = 10) by 40 min after agonist washout (Fig. 1, B and D).
|
20 min prior to application of DHPG. During incubation, lavendustin A had no effect on the basal sAHP or excitability (Fig. 2). Lavendustin did not significantly inhibit either the acute depression of the sAHP by DHPG (–87 ± 5%, n = 4; Fig. 2A) or the depression measured 40 min after agonist washout (–51 ± 8, n = 4; Fig. 2A). Lavendustin also did not significantly affect the increase in excitability induced by DHPG either during agonist application (7.4 ± 1.0 spikes/pulse above baseline, n = 4; Fig. 2B) or after 40 min washout (2.0 ± 1.3 spikes/pulse above baseline, n = 4; Fig. 2B). In separate experiments, we investigated the effect of an alternative tyrosine kinase inhibitor, genistein. Genistein (50 µM) did not affect the basal sAHP or excitability and did not significantly inhibit the acute depression of the sAHP by DHPG (–62 ± 17%, n = 4; Fig. 2A). However, genistein did significantly reduce the increase in excitability in response to DHPG (2.8 ± 1.0 spikes/pulse above baseline, n = 4, P < 0.05; Fig. 2B). Because genistein may exert significant nonspecific effects (Geissler et al. 1990), we employed a third tyrosine kinase inhibitor, PP2, which is a highly potent and specific inhibitor of the Src-family tyrosine kinases (Hanke et al. 1996). Src tyrosine kinases have been previously reported to mediate the signal transduction of mGluRs in hippocampal neurons (Heuss et al. 1999). PP2 (10 µM) did not affect the basal sAHP or excitability and also did not inhibit either the response of the sAHP to DHPG (sAHP, –99 ± 0.5%, n = 4; Fig. 2A) or the response of excitability to DHPG (10 ± 0.9 spikes/pulse above baseline, n = 4; Fig. 2B). The inhibitory effect of genistein on the mGluR-induced excitability increase may therefore have been due to a nonspecific effect of genistein, such as inhibition of ser/thr kinases, which it has been reported to also inhibit (Geissler et al. 1990). Taken together, these data indicate that the mGluR suppression of the sAHP and increase in excitability in CA1 pyramidal cells does not require the activation of tyrosine kinases that are sensitive to lavendustin A or PP2.
|
We next investigated whether tyrosine phosphatases are involved in the mGluR-mediated suppression of the sAHP because they have been reported to contribute to the DHPG-induced long-term depression of evoked synaptic potentials in CA1 (Moult et al. 2002). To achieve this, slices were preincubated for 20 min in 1 mM orthovanadate (Coussens et al. 2000; Gordon 1991; Moult et al. 2002). This treatment did not significantly affect the amplitude of the sAHP, although in some cells it caused an increase in sAHP width (data not shown) and on average caused a small but significant reduction in excitability (P < 0.05; Fig. 3B). In the presence of orthovanadate, the DHPG-induced depression of the sAHP was on average significantly reduced compared with that in the absence of orthovanadate (–53 ± 9%, n = 16, P < 0.005; Fig. 3A) as was the DHPG-induced increase in excitability (4.6 ± 1.1 spikes/pulse above baseline, n = 16, P < 0.05; Fig. 3B). Forty minutes after agonist washout both the sAHP (–51 ± 5%, n = 12) and excitability (2.6 ± 0.8 spikes/pulse above baseline, n = 12) had recovered to levels not different than those seen in experiments performed with DHPG alone. Interestingly, the sAHP in 8 of 16 cells appeared to be noticeably less sensitive to orthovanadate, and in general there was also less of an effect of orthovanadate on the mGluR-induced increase in excitability in those cells (Fig. 3E). The acute depression of the sAHP in these cells was only –18 ± 4% (n = 8) during DHPG application and –43 ± 12% (n = 4) after 40 min of agonist washout (Fig. 3C). In the same cells, excitability increased by only 1.1 ± 0.5 spikes/pulse above baseline (n = 8) during DHPG application and was 0.4 ± 0.7 spikes/pulse above baseline (n = 4) after 40 min of agonist washout (Fig. 3D). In the remainder of cells, the mean depression of the sAHP was –89 ± 4% (n = 8) during DHPG application and –55 ± 4% (n = 8) after 40 min of agonist washout (Fig. 3C). In these cells, excitability increased by 8.1 ± 1.0 spikes/pulse above baseline (n = 8) during DHPG application and was 4.0 ± 1.0 spikes/pulse above baseline after 40 min of agonist wash-out (n = 8) (Fig. 3D). These data demonstrate that in 
50% of CA1 neurons, tyrosine dephosphorylation plays an important role in the mGluR-dependent depression of the sAHP and the corresponding increase in excitability.
|
Because inhibition of tyrosine phosphatases could lead to an increase in tyrosine phosphorylation by tyrosine kinases, we next addressed whether increased tyrosine phosphorylation is required for inhibition of the mGluR effect by orthovanadate. Slices were preincubated in lavendustin A for 20 min prior to and during application of orthovanadate to inhibit tyrosine kinases and tyrosine phosphatases simultaneously. Under these conditions, DHPG produced an acute depression of the sAHP (–82 ± 5%, n = 10) that was significantly different to that in the presence of orthovanadate (P < 0.05) but was not significantly different to that with DHPG alone (Fig. 4A). These data suggest that the effects of orthovanadate on the mGluR-dependent depression of the sAHP are dependent on an associated increase in tyrosine kinase activity. They also confirm that the effects of orthovanadate that we have observed are mediated via changes in tyrosine phosphorylation rather than by nonspecific actions. Surprisingly, the increase in excitability in response to DHPG (4.9 ± 1.5 spikes/pulse above baseline, n = 10; Fig. 4B) was not significantly different to that in the presence of orthovanadate only, suggesting that other factors (e.g., other conductances) contributing to the excitability change may not be regulated in the same way.
|
The preceding data suggest that inhibition of tyrosine phosphatases with orthovanadate leads to an increase in tyrosine kinase activity. To investigate whether orthovanadate treatment directly affects tyrosine phosphorylation levels under our experimental conditions, we incubated hippocampal slices with either orthovanadate, lavendustin A, or both, for 20 min and carried out Western Blot analyses using an antibody that specifically recognizes phosphotyrosine residues. Orthovanadate caused a generalized increase in tyrosine phosphorylation after 20 min exposure compared with non-drug-treated controls (Fig. 5A). Densitometric analysis of the most prominent phosphotyrosine band (180 kDa) revealed a significant increase in tyrosine phosphorylation after 20 min orthovanadate exposure, relative to the untreated controls (Fig. 5B; 2.01 ± 0.39, n = 5, P < 0.05). This was reversed after 60 min of washing (1.02 ± 0.10, n = 5, data not shown). In contrast, lavendustin A did not significantly affect general tyrosine phosphorylation (Fig. 5A) or phosphorylation of the 180-kDa band (Fig. 5B; 0.89 ± 0.10, n = 5). In the presence of lavendustin A, orthovanadate appeared to cause a reduced effect on general tyrosine phosphorylation (Fig. 5A) and the 180-kDa band (1.68 ± 0.19, n = 5), but the increase was still significant (P < 0.05). This suggests that the tyrosine kinases blocked by lavendustin A are relatively minor contributors to the increase in generalized hippocampal tyrosine phosphorylation occurring in response to orthovanadate treatment.
|
We have previously shown that both mGluR1 and -5 contribute to the DHPG-induced depression of the sAHP and increase in excitability (Ireland and Abraham 2002). The possibility therefore exists that the bimodal effects of orthovanadate could be explained by a selective action on either the mGluR1- or mGluR5-signaling pathway. Because selective full agonists of mGluR1 and -5 are not available at present, we therefore used a combination of DHPG and specific antagonists to investigate this possibility. To assess the effects of orthovanadate on the mGluR1-mediated signaling pathway, we applied DHPG (20 µM) after prior incubation with orthovanadate plus the mGluR5-specific antagonist MPEP (10 µM). Under these conditions, DHPG depressed the sAHP by –27 ± 7% (n = 7; Fig. 6A). Consistent with orthovanadate having some inhibitory effect on the mGluR1-mediated component, this appeared to be a lesser degree of depression of the sAHP than seen in the absence of orthovanadate (–45 ± 14%, n = 7; Fig. 6A) (data taken from Ireland and Abraham 2002), although the difference was not significant. Conversely, to assess the effects of orthovanadate on mGluR5-mediated signaling pathways, we applied DHPG after prior incubation in orthovanadate plus the mGluR1-specific antagonist, LY367385 (100 µM). Under these conditions, DHPG depressed the sAHP by –34 ± 10% (n = 8; Fig. 6C), which like MPEP produced a nonsignificantly lesser depression than in the absence of orthovanadate (–57 ± 10%, n = 7; Fig. 6C), consistent with an inhibitory effect on the mGluR5-mediated component of the sAHP depression. These results suggest that orthovanadate does not selectively inhibit sAHP-depression by one mGluR subtype over the other.
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
). However, the dependence of the mGluR-mediated suppression of the sAHP on tyrosine dephosphorylation is somewhat surprising given the evidence for the involvement of serine/threonine kinases in the suppression of the sAHP by monoaminergic, kainic, and muscarinic agonists (Krause and Pedarzani 2000; Melyan et al. 2002; Pedarzani and Storm 1993, 1995, 1996), most probably by phosphorylation of the underlying Ca2+-activated K+ channels (KsAHP) and a consequent reduction in their open probability (Sah and Isaacson 1995). Furthermore, previous work in dentate gyrus granule cells found that the suppression of the sAHP is dependent on tyrosine kinases (Abdul-Ghani et al. 1996).
In the present study, we have revealed a role for a tyrosine phosphatase in promoting the mGluR-depression of the sAHP, but it appears that the importance of that role may vary across cells. This potentially could be explained by differences between mGluR1 and -5 in their sensitivity to orthovanadate and their relative abundance between cells. However, because we have shown that this is not an mGluR subtype-specific effect, an alternative explanation is that more than one signaling pathway, not all dependent on tyrosine dephosphorylation, could mediate the mGluR depression of the sAHP and that their relative importance or the level of redundancy between them could differ between neurons. Redundancy of mGluR signaling pathways has been previously demonstrated (Morikawa et al. 2003).
mGluR-suppression of the sAHP is gated by tyrosine dephosphorylation
One possible role of tyrosine phosphatases is to act as an essential component of the mGluR-triggered signaling pathway to depress the sAHP in the same way that monoamine transmitters are thought to depress the sAHP by activation of serine/threonine protein kinases that phosphorylate KsAHP and consequently alter channel opening (Pedarzani and Storm 1993; Sah and Isaacson 1995). However, dual lines of evidence argue against this interpretation. First activation of mGluRs has been shown to increase tyrosine phosphorylation (Siciliano et al. 1994), which is not consistent with activation of a tyrosine phosphatase. Second, if DHPG was suppressing the sAHP by decreasing tyrosine phosphorylation, then we would have expected to mimic the effect of DHPG by decreasing tyrosine phosphorylation via kinase inhibition. Instead, our results show that blocking tyrosine kinases does not mimic mGluR depression of the sAHP yet can rescue it from inhibition by tyrosine phosphatase blockade. A more likely role for the tyrosine phosphatase therefore seems to be a permissive one that "gates" the mGluR-activated transduction pathway(s) that are responsible for suppression of the sAHP as has been suggested for the serine/threonine phosphatase-dependent muscarinic depression of the sAHP (Krause and Pedarzani 2000). In this scenario (Fig. 7), a balance exists between tyrosine phosphorylation and dephosphorylation of a substrate protein(s). The basal level of this balance is weighted toward the nonphosphorylated state, which permits inhibition of the sAHP by mGluR activation. A disruption of this balance by inhibition of the tyrosine phosphatase leads to a consequent increase in substrate phosphorylation by tyrosine kinases. When this increase in phosphorylation is prevented by simultaneous inhibition of the tyrosine kinases, the relatively nonphosphorylated state and ability of DHPG to suppress the sAHP are maintained.
|
; Nouranifar et al. 1998; Pedarzani and Storm 1996; present study). An alternative possibility would be tyrosine dephosphorylation of either KsAHP itself or of the Ca2+ channels that supply Ca2+ to activate KsAHP, such that a relatively dephosphorylated state allows them to be inhibited by mGluR-activated signaling pathways. Both Ca2+-activated K+ channels and voltage-dependent Ca2+ channels can be regulated by tyrosine phosphorylation (Ling et al. 2000; Potier and Rovira 1999) although transmitter-suppression of the sAHP does not appear to be associated with a measurable change in the cytosolic Ca2+ transient (Charpak et al. 1990; Knopfel et al. 1990). A further possibility is tyrosine dephosphorylation of the mGluRs themselves or of a closely associated protein because mGluRs have been shown to be subject to tonic tyrosine phosphorylation and dephosphorylation, although it is not clear what effect tyrosine phosphorylation state has on receptor function (Orlando et al. 2002). In addition, based on the location of the tyrosine residues on mGluR5 (Minakami et al. 1997) it has been suggested that the tyrosine phosphorylation state of the receptor may not influence the activation of the phosphoinositide hydrolysis transduction pathway but might instead affect coupling of the receptor to non-PLC pathways (Orlando et al. 2002). This would be consistent with our previous conclusion that the mGluR depression of the sAHP is independent of PLC activity (Ireland and Abraham 2002). Tyrosine dephosphorylation could also regulate the function of an mGluR-associated protein such as Homer, which binds selectively to Group I mGluRs (Brakeman et al. 1997) and regulates their activity (Ango et al. 2001; Minami et al. 2003), localization (Ango et al. 2000; Serge et al. 2002), and interactions with other proteins (Kammermeier et al. 2000; Tu et al. 1998; Xiao et al. 1998). Functional implications
The afterhyperpolarization and cell excitability are increasingly thought to be important determinants of synaptic plasticity (Borde et al. 1999; Lancaster et al. 2001; Sah and Bekkers 1996), and it has been recently demonstrated that the mGluR-induced persistent reduction in the afterhyperpolarization results in improved precision and reliability of cell firing (Sourdet et al. 2003). Therefore the regulation of the mGluR-dependent suppression of the sAHP by tyrosine phosphorylation state raises the issue of what influence tyrosine dephosphorylation has on synaptic function and information transfer through a neuron. Forms of plasticity such as long-term potentiation (Cavus and Teyler 1996; Huang and Hsu 1999; O'Dell et al. 1991), paired-pulse facilitation (Moresco et al. 2003), and mGluR-dependent LTD (Camodeca et al. 1999) have been shown previously to be dependent on tyrosine kinase activity. Recently, tyrosine phosphatases have also been demonstrated to play a role in synaptic function and neuroplasticity, for example, in the regulation of mGluR-induced slow excitatory synaptic potentials in cerebellar Purkinje neurons (Canepari and Ogden 2003), in mGluR-dependent LTD in CA1 (Moult et al. 2002), and in the regulation of spatial learning (Skelton et al. 2003). An important question is what role does tyrosine phosphatase-dependent regulation of the sAHP play in other forms of synaptic plasticity, such as the mGluR-dependent "priming" of long-term potentiation (Cohen et al. 1999). Tyrosine dephosphorylation could represent an important means of regulating how a neuron reacts to incoming synaptic stimuli through a mechanism that gates the activity of signaling pathways.
|
GRANTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
|
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: D. R. Ireland, Dept. Psychology, University of Otago, P.O. Box 56, Dunedin, New Zealand (E-mail: direland{at}psy.otago.ac.nz).
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
Abdul-Ghani MA, Valiante TA, Carlen PL, and Pennefather PS. Tyrosine kinase inhibitors enhance a Ca-activated K current (IAHP) and reduce IAHP suppression by a metabotropic glutamate receptor agonist in rat dentate granule neurons. J Physiol 496: 139–144, 1996.
Ango F, Pin J-P, Tu JC, Xiao B, Worley PF, Bockaert J, and Fagni L. Dendritic and axonal targeting of type 5 metabotropic glutamate receptor is regulated by Homer1 proteins and neuronal excitation. J Neurosci 20: 8710–8716, 2000.
Ango F, Prezeau L, Muller T, Tu JC, Xiao B, Worley PF, Pin JP, Bockaert J, and Fagni L. Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature 411: 962–965, 2001.[CrossRef][Medline]
Aramori EC and Nakanishi S. Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells. Neuron 8: 757–765, 1992.[CrossRef][Web of Science][Medline]
Borde M, Bonansco C, and Buno W. The activity-dependent potentiation of the slow Ca2+-activated K+ current regulates synaptic efficacy in rat CA1 pyramidal neurons. Pfluegers Eur J Physiol 437: 261–266, 1999.[CrossRef]
Bortolotto ZA and Collingridge GL. Characterization of LTP induced by the activation of glutamate metabotropic receptors in area CA1 of the hippocampus. Neuropharmacology 32: 1–9, 1993.[CrossRef][Web of Science][Medline]
Brakeman PR, Lanahan AA, O'Brien R, Roche K, Barnes CA, Huganir RL, and Worley PF. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386: 284–288, 1997.[CrossRef][Medline]
Camodeca N, Breakwell NA, Rowan MJ, and Anwyl R. Induction of LTD by activation of group I mGluR in the dentate gyrus in vitro. Neuropharmacology 38: 1597–606, 1999.[CrossRef][Web of Science][Medline]
Canepari M and Ogden D. Evidence for protein tyrosine phosphatase, tyrosine kinase and G-protein regulation of the parallel fiber metabotropic slow EPSC of rat cerebellar Purkinje neurons. J Neurosci 23: 4066–4071, 2003.
Cavus I and Teyler T. Two forms of long-term potentiation in area CA1 activate different signal transduction cascades. J Neurophysiol 76: 3038–3047, 1996.
Charpak S, Gahwiler BH, Do KQ, and Knopfel T. Potassium conductances in hippocampal neurons blocked by excitatory amino-acid transmitters. Nature 347: 765–767, 1990.[CrossRef][Medline]
Cohen AS, Coussens CM, Raymond CR, and Abraham WC. Long-lasting increase in cellular excitability associated with the priming of LTP induction in rat hippocampus. J Neurophysiol 82: 3139–3148, 1999.
Coulter DA, Lo Turco JJ, Kubota M, Disterhoft JF, Moore JW, and Alkon DL. Classical conditioning reduces amplitude and duration of calcium-dependent afterhyperpolarization in rabbit hippocampal pyramidal cells. J Neurophyiol 61: 971–981, 1989.
Coussens CM, Williams JM, Ireland DR, and Abraham WC. Tyrosine phosphorylation-dependent inhibition of hippocampal synaptic plasticity. Neuropharmacology 39: 2267–2277, 2000.[CrossRef][Web of Science][Medline]
Geissler JF, Traxler P, Regenass U, Murray BJ, Roesel JL, Meyer T, McGlynn E, Storni A, and Lydon NB. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors. J Biol Chem 265: 22255–22261, 1990.
Gordon JA. Use of vanadate as protein phosphotyrosine phosphatase inhibitor. Methods Enzymol 201: 477–482, 1991.[Web of Science][Medline]
Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, and Connelly PA. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J Biol Chem 271: 695–701, 1996.
Huang C-C and Hsu K-S. Protein tyrosine kinase is required for the induction of long-term potentiation in the rat hippocampus. J Physiol 520: 783–796, 1999.
Heuss C, Scanziani M, Gahwiler BH, and Gerber U. G-protein-independent signaling mediated by metabotropic glutamate receptors. Nat Neurosci 2: 1070–1077, 1999.[CrossRef][Web of Science][Medline]
Ireland DR and Abraham WC. Group I mGluRs increase excitability of hippocampal CA1 pyramidal neurons by a PLC-independent mechanism. J Neurophyiol 88: 107–116, 2002.
Ireland DR and Abraham WC. mGluR-induced excitability change is dependent on tyrosine dephosphorylation in CA1 pyramidal neurons of the rat hippocampus. Sixth IBRO World Congress of Neuroscience, 2003.
Kammermeier PJ, Xiao B, Tu JC, Worley PF, and Ikeda SR. Homer proteins regulate coupling of Group I metabotropic glutamate receptors to N-type calcium and M-type potassium channels. J Neurosci 20: 7238–7245, 2000.
Knopfel T, Vranesic I, Gahwiler BH, and Brown DA. Muscarinic and 
-adrenergic depression of the slow Ca2+-activated potassium conductance in hippocampal CA3 pyramidal cells is not mediated by a reduction of depolarisation-induced cytosolic Ca2+ transients. Proc Natl Acad Sci USA 87: 4083–4087, 1990.
Krause M and Pedarzani P. A protein phosphatase is involved in the cholinergic suppression of the Ca2+-activated K+ current sIAHP in hippocampal pyramidal neurons. Neuropharmacology 39: 1274–1283, 2000.[CrossRef][Web of Science][Medline]
Lancaster B, Hu H, Ramakers GMJ, and Storm JF. Interaction between synaptic excitation and slow afterhyperpolarization current in rat hippocampal pyramidal cells. J Physiol 536: 809–823, 2001.
Linden DJ. The return of the spike: postsynaptic action potentials and the induction of LTP and LTD. Neuron 22: 661–666, 1999.[CrossRef][Web of Science][Medline]
Ling S, Woronuk G, Sy L, Lev S, and Braun AP. Enhanced activity of a large conductance, calcium-sensitive K+ channel in the presence of src tyrosine kinase. J Biol Chem 275: 30683–30689, 2000.
Mannaioni G, Attucci S, Missanelli A, Pellecciari R, Corradetti R, and Moroni F. Biochemical and electrophysiological studies on (S)-(+)-2-(3'-carboxybicyclo[1.1.1]pentyl)-glycine (CBPG), a novel mGlu5 receptor agonist endowed with mGlu1 receptor antagonist activity. Neuropharmacology 38: 917–926, 1999.[CrossRef][Web of Science][Medline]
Mannaioni G, Marino MJ, Valenti O, Traynelis SF, and Conn J. Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J Neurosci 21: 5925–5934, 2001.
Melyan Z, Wheal HV, and Lancaster B. Metabotropic-mediated kainite receptor regulation of IsAHP and excitability in pyramidal cells. Neuron 34: 107–114, 2002.[CrossRef][Web of Science][Medline]
Minakami R, Jinnai N, and Sugiyama H. Phosphorylation and calmodulin binding of the metabotropic glutamate subtype 5 (mGluR5) are antagonistic in vitro. J Biol Chem 272: 20291–20298, 1997.
Minami I, Kengaku M, Smitt PS, Shigemoto R, and Hirano T. Long-term potentiation of mGluR1 activity by depolarisation-induced Homer1a in mouse cerebellar Purkinje neurons. Eur J Neurosci 17: 1023–1032, 2003.[CrossRef][Web of Science][Medline]
Moresco EMY, Scheetz AJ, Bornmann WG, Koleske AJ, and Fitzsimonds RM. Abl family nonreceptor tyrosine kinases modulate short-term synaptic plasticity. J Neurophysiol 89: 1678–1687, 2003.
Morikawa H, Khodakhah K, and Williams JT. Two intracellular pathways mediate metaboptropic glutamate receptor-induced Ca2+ mobilization in dopamine neurons. J Neurosci 23: 149–157, 2003.
Moult PR, Schnabel R, Kilpatrick IC, Bashir ZI, and Collingridge GL. Tyrosine dephosphorylation underlies DHPG-induced LTD. Neuropharmacology 43: 175–180, 2002.[CrossRef][Web of Science][Medline]
Nouranifar R, Blitzer RD, Wong T, and Landau E. Metabotropic glutamate receptors limit adenyl cyclase-mediated effects in rat hippocampus via protein kinase C. Neurosci Lett 244: 101–105, 1998.[CrossRef][Web of Science][Medline]
O'Dell TJ, Kandel ER, and Grant SGN. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature 353: 558–560, 1991.[CrossRef][Medline]
Orlando LR, Dunah AW, Standaert DG, and Young AB. Tyrosine phosphorylation of the metabotropic glutamate receptor mGluR5 in striatal neurons. Neuropharmacology 43: 161–173, 2002.[CrossRef][Web of Science][Medline]
Pedarzani P and Storm JF. PKA mediates the effects of monoamine transmitters on the K+ current underlying the slow spike frequency adaptation in hippocampal neurons. Neuron 11: 1023–1035, 1993.[CrossRef][Web of Science][Medline]
Pedarzani P and Storm JF. Dopamine modulates the slow Ca2+-activated K+ current IsAHP via cyclic AMP-dependent protein kinase in hippocampal neurons. J Neurophysiol 74: 2749–2753, 1995.
Pedarzani P and Storm JF. Evidence that Ca/calmodulin-dependent protein kinase mediates the modulation of the Ca2+-dependent K+ current, IAHP, by acetylcholine, but not by glutamate, in hippocampal neurons. Pfluegers Eur J Physiol 431: 723–728, 1996.
Potier B and Rovira C. Protein tyrosine kinase inhibitors reduce high-voltage activating calcium currents in CA1 pyramidal neurones from rat hippocampal slices. Br Res 816: 587–597, 1999.[CrossRef][Web of Science][Medline]
Sah P and Bekkers JM. Apical dendritic location of slow afterhyperpolarization current in hippocampal pyramidal neurons: implications for the integration of long-term potentiation. J Neurosci 16: 4537–4542, 1996.
Sah P and Isaacson JS. Channels underlying the slow afterhyperpolarization in hippocampal pyramidal neurons: neurotransmitters modulate the open probability. Neuron 15: 435–441, 1995.[CrossRef][Web of Science][Medline]
Schrader LA, Anderson AE, Varga AW, Levy M, and Sweatt JD. The other half of Hebb. Mol Neurobiol 25: 51–66, 2002.[CrossRef][Web of Science][Medline]
Serge A, Fourgeaud L, Hemar A, and Choquet D. Receptor activation and Homer differentially control the lateral mobility of metabotropic glutamate receptor 5 in the neuronal membrane. J Neurosci 22: 3910–3920, 2002.
Siciliano JC, Gelman M, and Girault J-A. Depolarization and neurotransmitters increase neuronal protein tyrosine phosphorylation. J Neurochem 62: 950–959, 1994.[Web of Science][Medline]
Skelton MR, Ponniah S, Wang DZM, Doetschman T, Vorhees CV, and Pallen CJ. Protein tyrosine phosphatase alpha (PTP) knockout mice show deficits in Morris water maze learning, decreased locomotor activity, and decreases in anxiety. Br Res 984: 1–10, 2003.[CrossRef][Web of Science][Medline]
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC. Measurement of protein using bicinchoninic acid. Ann Biochem 150: 76–85, 1985.
Sourdet V, Russier M, Daoudal G, Ankri N, and Debanne D. Long-term enhancement of neuronal excitability and temporal fidelity mediated by metabotropic glutamate receptor subtype 5. J Neurosci 23: 10238–10248, 2003.
Storm JF. Potassium currents in hippocampal pyramidal cells. Prog Brain Res 83: 161–187, 1990.[Web of Science][Medline]
Tu JC, Xiao B, Yuan JP, Lanahan AA, Leoffert K, Li M, Linden DJ, and Worley PF. Homer binds a novel proline-rich motif and links Group I metabotropic glutamate receptors with IP3 receptors. Neuron 21: 717–726, 1998.[CrossRef][Web of Science][Medline]
Williams JM, Mason-Parker SE, Abraham WC, and Tate WP. Biphasic changes in the levels of N-methyl-D-aspartate receptor-2 subunits correlate with the induction and persistence of long term- potentiation. Mol Brain Res 60: 21–27, 1998.[Medline]
Xiao B, Tu JC, Petralia RS, Yuan JP, Doan A, Breder CD, Ruggiero A, Lanahan AA, Wenthold RJ, and Worley PF. Homer regulates the association of Group I metabotropic glutamate receptors with multivalent complexes of Homer-related, synaptic proteins. Neuron 21: 707–716, 1998.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
|
|
 |
|
  J. T. Brown and A. D. Randall Activity-dependent depression of the spike after-depolarization generates long-lasting intrinsic plasticity in hippocampal CA3 pyramidal neurons J. Physiol., March 15, 2009; 587(6): 1265 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Ireland and W. C. Abraham Mechanisms of Group I mGluR-Dependent Long-Term Depression of NMDA Receptor-Mediated Transmission at Schaffer Collateral-CA1 Synapses J Neurophysiol, March 1, 2009; 101(3): 1375 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ferraguti, L. Crepaldi, and F. Nicoletti Metabotropic Glutamate 1 Receptor: Current Concepts and Perspectives Pharmacol. Rev., December 1, 2008; 60(4): 536 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Young, R. Bianchi, and R. K. S. Wong Signaling Mechanisms Underlying Group I mGluR-Induced Persistent AHP Suppression in CA3 Hippocampal Neurons J Neurophysiol, March 1, 2008; 99(3): 1105 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sheng, Y. Zhang, J. Sun, L. Gao, B. Ma, J. Lu, and X. Ni Corticotropin-Releasing Hormone (CRH) Depresses N-Methyl-D-Aspartate Receptor-Mediated Current in Cultured Rat Hippocampal Neurons via CRH Receptor Type 1 Endocrinology, March 1, 2008; 149(3): 1389 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Y. Chang, P. E. Taylor, and M. B. Jackson Voltage Imaging Reveals the CA1 Region at the CA2 Border as a Focus for Epileptiform Discharges and Long-Term Potentiation in Hippocampal Slices J Neurophysiol, September 1, 2007; 98(3): 1309 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Canepari and D. Ogden Kinetic, pharmacological and activity-dependent separation of two Ca2+ signalling pathways mediated by type 1 metabotropic glutamate receptors in rat Purkinje neurones J. Physiol., May 15, 2006; 573(1): 65 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Moult, C. M. Gladding, T. M. Sanderson, S. M. Fitzjohn, Z. I. Bashir, E. Molnar, and G. L. Collingridge Tyrosine Phosphatases Regulate AMPA Receptor Trafficking during Metabotropic Glutamate Receptor-Mediated Long-Term Depression J. Neurosci., March 1, 2006; 26(9): 2544 - 2554. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
), 50 µM genistein (
), or PP2 (
). B: change in number of action potentials in a train evoked by a 250-ms, 0.5-nA depolarizing pulse in the same cells as in A. - - -, period of exposure to antagonists.
, a prominent 180-kDa band. —, position of molecular weight markers (200, 116, 97, 66, 45 kDa). B: summary histogram of Western Blot experiments (n = 5) in which each column represents the average band density in relative absorbance units (drug/no drug) for the 180-kDa band. Error bars indicate SE. *, a significant difference from no-drug group. C: summary histogram in which each column represents the average percent depression of the sAHP under the conditions labeled. Error bars indicate SE. *, a significant difference from DHPG group.
